These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 14745050)

  • 21. Towards seeing the visual impairments in Parkinson's disease: protocol for a multicentre observational, cross-sectional study.
    Borm CDJM; Werkmann M; Visser F; Peball M; Putz D; Seppi K; Poewe W; Notting IC; Vlaar A; Theelen T; Hoyng C; Bloem BR; de Vries NM
    BMC Neurol; 2019 Jun; 19(1):141. PubMed ID: 31238904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular and visual discomfort associated with smartphones, tablets and computers: what we do and do not know.
    Jaiswal S; Asper L; Long J; Lee A; Harrison K; Golebiowski B
    Clin Exp Optom; 2019 Sep; 102(5):463-477. PubMed ID: 30663136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diurnal variation of visual function and the signs and symptoms of dry eye.
    Walker PM; Lane KJ; Ousler GW; Abelson MB
    Cornea; 2010 Jun; 29(6):607-12. PubMed ID: 20458235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel disease.
    Cloché V; Buisson A; Tréchot F; Batta B; Locatelli A; Favel C; Premy S; Collet-Fenetrier B; Fréling E; Lopez A; Massoure MP; Humbert AL; Hansmannel F; Guéant JL; Bigard MA; Peyrin-Biroulet L; Angioi K
    Dig Liver Dis; 2013 Mar; 45(3):195-9. PubMed ID: 23200464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked.
    Ekker MS; Janssen S; Seppi K; Poewe W; de Vries NM; Theelen T; Nonnekes J; Bloem BR
    Parkinsonism Relat Disord; 2017 Jul; 40():1-10. PubMed ID: 28284903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of dementia and visual hallucinations in tremor and non-tremor dominant Parkinson's disease.
    Rana AQ; Vaid HM; Edun A; Dogu O; Rana MA
    J Neurol Sci; 2012 Dec; 323(1-2):158-61. PubMed ID: 23062324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of diplopia in non-demented patients with Parkinson's disease.
    Schindlbeck KA; Schönfeld S; Naumann W; Friedrich DJ; Maier A; Rewitzer C; Klostermann F; Marzinzik F
    Parkinsonism Relat Disord; 2017 Dec; 45():1-6. PubMed ID: 28993094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Features associated with the development of hallucinations in Parkinson's disease.
    Benbir G; Ozekmekçi S; Cinar M; Beskardes F; Apaydin H; Erginöz E
    Acta Neurol Scand; 2006 Oct; 114(4):239-43. PubMed ID: 16942542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vision loss and hallucinations: perspectives from neurology and ophthalmology.
    Hamedani AG
    Curr Opin Neurol; 2021 Feb; 34(1):84-88. PubMed ID: 33230034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary FMRI evidence of visual system dysfunction in Parkinson's disease patients with visual hallucinations.
    Holroyd S; Wooten GF
    J Neuropsychiatry Clin Neurosci; 2006; 18(3):402-4. PubMed ID: 16963591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor visual discrimination and visual hallucinations in Parkinson's disease.
    Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
    Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual Dysfunction in Parkinson's Disease.
    Nieto-Escamez F; Obrero-Gaitán E; Cortés-Pérez I
    Brain Sci; 2023 Aug; 13(8):. PubMed ID: 37626529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of ocular changes in leprosy patients.
    Monteiro LG; Campos WR; Oréfice F; Grossi MA
    Indian J Lepr; 1998; 70(2):197-202. PubMed ID: 9724855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seeing ophthalmologic problems in Parkinson disease: Results of a visual impairment questionnaire.
    Borm CDJM; Visser F; Werkmann M; de Graaf D; Putz D; Seppi K; Poewe W; Vlaar AMM; Hoyng C; Bloem BR; Theelen T; de Vries NM
    Neurology; 2020 Apr; 94(14):e1539-e1547. PubMed ID: 32161030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can Binocular Vision Disorders Contribute to Contact Lens Discomfort?
    Rueff EM; King-Smith PE; Bailey MD
    Optom Vis Sci; 2015 Sep; 92(9):e214-21. PubMed ID: 26164313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Visual Dysfunction in Patients with Parkinson's Disease.
    Savitt J; Aouchiche R
    J Parkinsons Dis; 2020; 10(s1):S49-S56. PubMed ID: 32741840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effect of lens care solutions on blink rate, ocular discomfort and visual performance.
    Yang SN; Tai YC; Sheedy JE; Kinoshita B; Lampa M; Kern JR
    Ophthalmic Physiol Opt; 2012 Sep; 32(5):412-20. PubMed ID: 22775005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing an aetiological model of visual hallucinations in Parkinson's disease.
    Gallagher DA; Parkkinen L; O'Sullivan SS; Spratt A; Shah A; Davey CC; Bremner FD; Revesz T; Williams DR; Lees AJ; Schrag A
    Brain; 2011 Nov; 134(Pt 11):3299-309. PubMed ID: 21921019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ocular and visual alterations in computer workers contact lens wearers: scoping review].
    Tauste Francés A; Ronda-Pérez E; Seguí Crespo Mdel M
    Rev Esp Salud Publica; 2014; 88(2):203-15. PubMed ID: 24914860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual exploration of emotional facial expressions in Parkinson's disease.
    Clark US; Neargarder S; Cronin-Golomb A
    Neuropsychologia; 2010 Jun; 48(7):1901-13. PubMed ID: 20230847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.